Search
Discover how our breakthroughs are helping kids with diabetes live longer, safer lives.
Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.
The MELODY Study is a Phase 3 randomized, double-blind, placebo-controlled, single-dose study to determine if MEDI8897 will prevent medically attended Respiratory Syncytial Virus (RSV) -confirmed Lower Respiratory Tract Infection (LRTI) in healthy infants entering their first RSV season.
The study is a phase 3, Multicentre, Randomised, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Health Infants.
Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
The QUINTET Study will evaluate the effectiveness of a potential vaccine called MenABCWY.
Graham Jenny Peter Hall Downs Jacoby BAppSci PhD CRFS FANZSRS FThorSoc FERS BApplSci (physio) MSc PhD BA (Hons) MSc Honorary Research Associate Head,
Gail Andrew Videos Alvares Whitehouse Watch and listen to Andrew PhD PhD Principal Research Fellow Deputy Director (Research); Angela Wright Bennett
This study aims to investigate a new vaccine which has been developed to protect children from RSV.
Peter Ruth Elke Richmond Thornton Seppanen MBBS MRCP(UK) FRACP PhD BSc PhD Head, Vaccine Trials Group Co-head, Bacterial Respiratory Infectious